AN AQUEOUS INTRAVENOUS NANOSUSPENSION WITH REDUCED ADVERSE EFFECTS
摘要
The present invention relates to an aqueous nanosuspension formulation comprising a drug possessing low intrinsic water solubility, e.g. amiodarone. It also provides a method for the preparation of intravenous formulation comprising amiodarone, with markedly decreased adverse effects.
申请公布号
WO2011080148(A3)
申请公布日期
2012.03.29
申请号
WO2010EP70304
申请日期
2010.12.20
申请人
LEK PHARMACEUTICALS D.D.;HOMAR, MIHA;CEGNAR, MATEJA;LOVSE BARLE, ESTER;PETERNEL, LUKA;KERC, JANEZ
发明人
HOMAR, MIHA;CEGNAR, MATEJA;LOVSE BARLE, ESTER;PETERNEL, LUKA;KERC, JANEZ
